Polymorphisms in Translesion Polymerase Genes Influence Treatment Outcome in Malignant Mesothelioma

References

• Kovac V , ZwitterM , ZagarT . Improved survival after introduction of chemotherapy for malignant pleural mesothelioma in Slovenia: population-based survey of 444 patients . Radiol. Oncol.46 ( 2 ), 136 – 144 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Damhuis RA , SchrotenC , BurgersJA . Population-based survival for malignant mesothelioma after introduction of novel chemotherapy . Eur. Respir. J.40 ( 1 ), 185 – 189 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kovac V , ZwitterM , RajerMet al. A Phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma . Anticancer Drugs23 ( 2 ), 230 – 238 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Lee CW , MurrayN , AndersonH , RaoSC , BishopW . Outcomes with first-line platinum-based combination chemotherapy for malignant pleural mesothelioma: a review of practice in British Columbia . Lung Cancer64 ( 3 ), 308 – 313 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Enoiu M , JiricnyJ , ScharerOD . Repair of cisplatin-induced DNA interstrand crosslinks by a replication-independent pathway involving transcription-coupled repair and translesion synthesis . Nucleic Acids Res.40 ( 18 ), 8953 – 8964 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Sharma S , CanmanCE . REV1 and DNA polymerase zeta in DNA interstrand crosslink repair . Environ. Mol. Mutagen.53 ( 9 ), 725 – 740 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Ho TV , ScharerOD . Translesion DNA synthesis polymerases in DNA interstrand crosslink repair . Environ. Mol. Mutagen.51 ( 6 ), 552 – 566 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Makridakis NM , ReichardtJK . Translesion DNA polymerases and cancer . Front. Genet.3 , 174 ( 2012 ).
   PubMedGoogle Scholar
• Lin X , OkudaT , TrangJ , HowellSB . Human REV1 modulates the cytotoxicity and mutagenicity of cisplatin in human ovarian carcinoma cells . Mol. Pharmacol.69 ( 5 ), 1748 – 1754 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Doles J , OliverTG , CameronERet al. Suppression of Rev3, the catalytic subunit of Pol{zeta}, sensitizes drug-resistant lung tumors to chemotherapy . Proc. Natl Acad. Sci. USA107 ( 48 ), 20786 – 20791 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Sakiyama T , KohnoT , MimakiSet al. Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk . Int. J. Cancer114 ( 5 ), 730 – 737 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Varadi V , BevierM , GrzybowskaEet al. Genetic variation in genes encoding for polymerase zeta subunits associates with breast cancer risk, tumour characteristics and survival . Breast Cancer Res. Treat.129 ( 1 ), 235 – 245 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Pan J , ChiP , LuX , XuZ . Genetic polymorphisms in translesion synthesis genes are associated with colorectal cancer risk and metastasis in Han Chinese . Gene504 ( 2 ), 151 – 155 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Zhang S , ChenH , ZhaoXet al. REV3L 3′UTR 460 T>C polymorphism in microRNA target sites contributes to lung cancer susceptibility . Oncogene32 ( 2 ), 242 – 250 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• He X , YeF , ZhangJ , ChengQ , ShenJ , ChenH . REV1 genetic variants associated with the risk of cervical carcinoma . Eur. J. Epidemiol.23 ( 6 ), 403 – 409 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Byrne MJ , NowakAK . Modified RECIST criteria for assessment of response in malignant pleural mesothelioma . Ann. Oncol.15 ( 2 ), 257 – 260 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• CTCAE v4.0 Open Comment Period . http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm  
   Google Scholar
• Xu Z , TaylorJA . SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies . Nucleic Acids Res.37 ( Web Server issue ), W600 – W605 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Tregouet DA , GarelleV . A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies . Bioinformatics23 ( 8 ), 1038 – 1039 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Erculj N , KovacV , HmeljakJ , FrankoA , Dodic-FikfakM , DolzanV . The influence of gemcitabine pathway polymorphisms on treatment outcome in patients with malignant mesothelioma . Pharmacogenet. Genomics22 ( 1 ), 58 – 68 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Erculj N , KovacV , HmeljakJ , FrankoA , Dodic-FikfakM , DolzanV . DNA repair polymorphisms and treatment outcomes of patients with malignant mesothelioma treated with gemcitabine-platinum combination chemotherapy . J. Thorac. Oncol.7 ( 10 ), 1609 – 1617 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Erculj N , KovacV , HmeljakJ , DolzanV . The influence of platinum pathway polymorphisms on the outcome in patients with malignant mesothelioma . Ann. Oncol.23 ( 4 ), 961 – 967 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Xu X , XieK , ZhangXQet al. Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug . Proc. Natl Acad. Sci. USA110 ( 46 ), 18638 – 18643 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lange SS , TakataK , WoodRD . DNA polymerases and cancer . Nat. Rev. Cancer11 ( 2 ), 96 – 110 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Wittschieben JP , ReshmiSC , GollinSM , WoodRD . Loss of DNA polymerase zeta causes chromosomal instability in mammalian cells . Cancer Res.66 ( 1 ), 134 – 142 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Wittschieben JP , PatilV , GlushetsV , RobinsonLJ , KusewittDF , WoodRD . Loss of DNA polymerase zeta enhances spontaneous tumorigenesis . Cancer Res.70 ( 7 ), 2770 – 2778 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Mazzoni F , CecereFL , MeoniGet al. Phase II trial of customized first line chemotherapy according to ERCC1 and RRM1 SNPs in patients with advanced non-small-cell lung cancer . Lung Cancer82 ( 2 ), 288 – 293 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Ren S , ZhouS , WuFet al. Association between polymorphisms of DNA repair genes and survival of advanced NSCLC patients treated with platinum-based chemotherapy . Lung Cancer75 ( 1 ), 102 – 109 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Bonanno L . Predictive models for customizing chemotherapy in advanced non-small cell lung cancer (NSCLC) . Transl. Lung Cancer Res.2 ( 3 ), 160 – 171 ( 2013 ).
   PubMedGoogle Scholar